TITLE

Myasthenia Gravis Remission and Neuromuscular Considerations

AUTHOR(S)
Spal, Katherine
PUB. DATE
August 2010
SOURCE
International Student Journal of Nurse Anesthesia;Summer2010, Vol. 9 Issue 2, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
This case highlights the implications of myasthenia gravis when developing an anesthetic plan. Additionally, this report discusses the successful use of neuromuscular antagonism in a seropositive patient with high levels of acetylcholine receptor antibodies that demonstrated no signs or symptoms of current disease and was considered to be in remission at the time of general anesthesia.
ACCESSION #
53170902

 

Related Articles

  • Vecuronium bromide.  // Reactions Weekly;8/1/2013, Issue 1463, p37 

    The article presents a case study of a 68-year old woman who went through protracted neuromuscular blockade following administration of vecuronium bromide, and latent myasthenia gravis was revealed.

  • Onset of vecuronium-induced neuromuscular block after a long priming interval. Saitoh, Yuhji; Kaneda, Koh; Murakawa, Masahiro // Journal of Anesthesia;2002, Vol. 16 Issue 2, p102 

    .Purpose. We examined whether a new application of the priming principle, i.e., having the priming dose of vecuronium administered before the insertion of the epidural catheter, would hasten the onset of the neuromuscular block induced by the intubating dose of vecuronium.Methods. Forty-five...

  • Timeline: Unravelling the pathogenesis of myasthenia gravis. Vincent, Angela // Nature Reviews Immunology;Oct2002, Vol. 2 Issue 10, p797 

    Myasthenia gravis is a relatively rare neurological disease that is associated with loss of the acetylcholine receptors that initiate muscle contraction. This results in muscle weakness, which can be life-threatening. The story of how both the physiological basis of the disease and the role of...

  • Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis. Blaha, M.; Pitha, J.; Blaha, V.; Lanska, M.; Maly, J.; Filip, S.; Langrova, H. // Journal of Biomedicine & Biotechnology;2010, p1 

    Myasthenia gravis (MG) is a neuromuscular disorder leading to fluctuating muscle weakness and fatigue. Rarely, long-term stabilization is not possible through the use of thymectomy or any known drug therapy. We present our experience with extracorporeal immunoglobulin (Ig) elimination by...

  • Myasthenia gravis and acetylcholine receptor antibodies: A clinico immunological correlative study on South Indian patients. Bindu, P. S.; Nirmala, M.; Patil, S. A.; Taly, A. B. // Annals of Indian Academy of Neurology;Oct2008, Vol. 11 Issue 4, p242 

    Acquired myasthenia Gravis (MG), a disorder of impaired neuromuscular transmission is recognized as an autoimmune disorder, with a majority of the patients having antibodies against acetylcholine receptor (AChR antibodies) in the serum. Aim and Objectives: To correlate the AChR antibody status...

  • Duration of vecuronium-induced neuromuscular block can be predicted by change of skin temperature over the thenar muscles. Suzuki, Takahiro; Kitajima, Osamu; Watanabe, Aiko; Nonaka, Hiroko; Saeki, Shigeru; Ogawa, Setsuro // Journal of Anesthesia;2004, Vol. 18 Issue 3, p172 

    Purpose. The purpose of this study was to clarify the relationship between skin temperature over the thenar muscles and the duration of action of vecuronium measured acceleromyographically at the thumb in anesthetized patients. Methods. In 15 patients undergoing elective open abdominal surgery...

  • Recovery of neuromuscular blockade caused by vecuronium is delayed in patients with hypertriglyceridemia. Saitoh, Yuhji; Oshima, Tsutomu; Nakata, Yoshinori // Journal of Anesthesia;2008, Vol. 22 Issue 1, p89 

    We investigated the effects of hypertriglyceridemia on the onset and recovery of neuromuscular blockade, induced by vecuronium, over the adductor pollicis muscle, electromyographically. Eighteen adult patients with hypertriglyceridemia (hypertriglyceridemia group) and 18 healthy patients with...

  • Monitoring of vecuronium-induced neuromuscular block at the sternocleidomastoid muscle in anesthetized patients. Saitoh, Yuhji; Oshima, Tsutomu; Nakata, Yoshinori // Journal of Anesthesia;2010, Vol. 24 Issue 6, p838 

    Purpose: To assess the degree of neuromuscular block acceleromyographically at the sternocleidomastoid muscle. Methods: Eighteen adult patients scheduled for air-oxygen-sevoflurane-fentanyl and epidural anesthesia were studied. In the patients, the right accessory nerve and the...

  • Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days. Johnson, Cary E.; Cober, Mary Petrea // American Journal of Health-System Pharmacy;11/15/2007, Vol. 64 Issue 22, p2356 

    Purpose. The stability of vecuronium bromide 1 mg/mL in preservative-free sterile water for injection for up to 21 days was studied. Methods. A vecuronium bromide 1-mg/mL solution was prepared by diluting 15 vials of 10-mg Vecuronium Bromide for Injection, USP, powder with preservative-free...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics